We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIIIU
526
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$8.83M 0.04%
+890,451
New +$8.95M
WALDU
527
DELISTED
Waldencast Acquisition Corp. Units
WALDU
$8.82M 0.04%
+883,356
New +$8.87M
SLCRU
528
DELISTED
Silver Crest Acquisition Corporation Unit
SLCRU
$8.82M 0.04%
+888,481
New +$9.08M
FLNA
529
Filana Therapeutics
FLNA
$43M
$8.81M 0.04%
195,942
-211,864
-52% -$8.33M
PDOT.U
530
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
$8.81M 0.04%
+885,902
New +$8.81M
COP icon
531
ConocoPhillips
COP
$147B
$8.77M 0.04%
165,595
+121,506
+276% +$5.99M
SPWH icon
532
Sportsman's Warehouse
SPWH
$43.7M
$8.71M 0.04%
505,255
-2,044
-0.4% -$35.6K
TCF
533
DELISTED
TCF Financial Corporation Common Stock
TCF
$8.67M 0.04%
186,666
+161,658
+646% +$7.15M
JD icon
534
CALL
JD.com
JD
$40.8B
$8.67M 0.04%
+102,800
New +$9.43M
PBR.A icon
535
Petrobras Class A
PBR.A
$107B
$8.65M 0.04%
1,013,061
+951,710
+1,551% +$9.04M
SNA icon
536
Snap-on
SNA
$20.9B
$8.63M 0.04%
37,390
+24,182
+183% +$4.76M
HUGS.U
537
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$8.59M 0.04%
+854,616
New +$8.67M
PMVC
538
DELISTED
PMV Consumer Acquisition Corp.
PMVC
$8.56M 0.04%
+882,725
New +$8.97M
SEM
539
DELISTED
Select Medical
SEM
$8.56M 0.04%
+465,945
New +$7.64M
REGN icon
540
Regeneron Pharmaceuticals
REGN
$68.8B
$8.55M 0.04%
18,068
+15,448
+590% +$7.52M
AUS.U
541
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$8.53M 0.04%
+849,795
New +$8.63M
BOAS.U
542
DELISTED
BOA Acquisition Corp. Units, each consisting of one share of Class A common stock, and one third of one redeemable warrant
BOAS.U
$8.5M 0.04%
+857,500
New +$8.57M
MRVI icon
543
Maravai LifeSciences
MRVI
$997M
$8.45M 0.04%
237,185
-125,795
-35% -$4.17M
IWO icon
544
PUT
iShares Russell 2000 Growth ETF
IWO
$14.5B
$8.45M 0.04%
28,100
-59,200
-68% -$18.4M
PNC icon
545
PNC Financial Services
PNC
$100B
$8.42M 0.04%
48,021
+16,946
+55% +$2.8M
EQHA.U
546
DELISTED
EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
EQHA.U
$8.39M 0.04%
+846,237
New +$8.58M
ABX
547
Abacus Global Management
ABX
$996M
$8.32M 0.04%
851,127
+197,534
+30% +$2.02M
PLD icon
548
Prologis
PLD
$138B
$8.31M 0.04%
+78,421
New +$7.99M
QGEN icon
549
Qiagen
QGEN
$8.53B
$8.3M 0.04%
161,362
-311,897
-66% -$17.1M
HESM icon
550
Hess Midstream
HESM
$5.22B
$8.28M 0.04%
+369,187
New +$7.96M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.